Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 10.08.2026 1 Acta Cardiol 1 Adv Rheumatol 1 Am Heart J Plus 1 Am J Cardiol 1 Ann Am Thorac Soc 1 AsiaIntervention 1 ATS Sch 1 BMJ Open 1 Cardiol Rev 1 Cardiovasc Ultrasound 2 CHEST Pulm 1 Clin Genet 2 Clin Respir J 3 Cureus 3 Curr Opin Pulm Med 1 Eur Heart J Digit Health 1 Eur Radiol 3 Eur Respir J 1 Eur Respir Rev 1 Expert Opin Drug Saf 1 Front Cardiovasc Med 1 Front Pharmacol 1 Heart Lung Circ 1 Histochem Cell Biol 1 Hum Mutat 1 J Am Heart Assoc 1 J Assoc Physicians India 1 J Cell Mol Med 2 J Hypertens 1 J Perinatol 1 J Rheumatol 1 J Vis Exp 1 JACC Heart Fail 1 Lancet 1 Medicine (Baltimore) 1 Niger Med J 1 Pediatr Cardiol 1 Pediatr Res 1 Pharmacol Ther 1 Placenta 1 Psychol Res Behav Manag 2 Pulm Circ 1 Res Sq 1 Rheumatology (Oxford) 1 Zh Nevrol Psikhiatr Im S S Korsakova 1 Zhonghua Jie He He Hu Xi Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Cardiol

1. FAIZ A, Gulalai W
   Pulmonary hypertension in beta-thalassaemia: methodological considerations and future directions.
   Acta Cardiol. 2026 Aug 3:1-2. doi: 10.1080/00015385.2026.2712732.
   PubMed        
   
   

   
   Adv Rheumatol

2. HAO Y, Montes R, Oon S, Nikpour M, et al
   Management of inflammatory cardiopulmonary manifestations in systemic lupus erythematosus: a systematic review.
   Adv Rheumatol. 2026;66:47.
   PubMed         Abstract available
   
   

   
   Am Heart J Plus

3. KOTHARI SS
   Risk stratification in post operative pulmonary hypertension: Insights from the the japanese association of congenital heart disease registry (JACPHR) members.
   Am Heart J Plus. 2026;69:100840.
   PubMed        
   
   

   
   Am J Cardiol

4. KIYOHARA Y, Sakai T, Freeman LM, Katzianer D, et al
   Pulmonary Arterial Hypertension-Targeted Therapy for Pulmonary Hypertension Associated with Left Heart Disease: Bayesian and Frequentist Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2026 Aug 4:S0002-9149(26)00476.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

5. ROJAS A, Morales DLS, Wikenheiser-Brokamp KA, Hayes D Jr, et al
   Unusual Clinical Course of Pediatric Pulmonary Hypertension with Underlying SOX17 Mutation.
   Ann Am Thorac Soc. 2026 Aug 3:aaoag216. doi: 10.1093.
   PubMed        
   
   

   
   AsiaIntervention

6. NAGAYOSHI S, Fujii S, Shimizu Y, Miyamoto T, et al
   Mechanical thrombus removal using biopsy forceps for recurrent CTO reocclusion in chronic thromboembolic pulmonary hypertension.
   AsiaIntervention. 2026;12:e164-e165.
   PubMed        
   
   

   
   ATS Sch

7. WEERASEKARE JM, Rosen J, Kopras EJ, Elwing J, et al
   Pulmonary Hypertension Training in Pulmonary & Critical Care Medicine Fellowship: A National Survey.
   ATS Sch. 2026 Jul 31:aapag040. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   BMJ Open

8. RODENBURG TC, Boerman S, Post M, Bogaard HJ, et al
   STOP-RIO study: protocol for a randomised, controlled, open-label non-inferiority trial to test the safety of discontinuation of riociguat after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
   BMJ Open. 2026;16:e120820.
   PubMed         Abstract available
   
   

   
   Cardiol Rev

9. JABEEN M, Younas S, Majid A, Fatima H, et al
   Left Atrial Myopathy as a Phenotypic Axis in HFpEF: Implications for Pulmonary Hypertension, Exercise Intolerance, and Targeted Therapy.
   Cardiol Rev. 2026 Aug 8. doi: 10.1097/CRD.0000000000001423.
   PubMed         Abstract available
   
   

   
   Cardiovasc Ultrasound

10. PUTORTI F, Fabris T, Mesiani C, Tripi S, et al
    Right ventricular-pulmonary artery uncoupling identifies higher risk of combined pulmonary hypertension in patients undergoing TAVR.
    Cardiovasc Ultrasound. 2026;24:17.
    PubMed         Abstract available
    
    

    
    CHEST Pulm

11. AGUADO B, Lacoste-Palasset T, Favard F, Palat S, et al
    A Proof of Concept for the Use of Lung Ultrasound in the Diagnostic Approach of Pulmonary Hypertension.
    CHEST Pulm. 2025;4:100225.
    PubMed        
    
    
12. SCHWALBACH KT, Annis J, Garry JD, Nian H, et al
    Incidence and Clinical Associations With Phenotypic Drift From Pulmonary Arterial Hypertension to Combined Precapillary and Postcapillary Pulmonary Hypertension.
    CHEST Pulm. 2025;3:100206.
    PubMed         Abstract available
    
    

    
    Clin Genet

13. ALDALAAN A, Nadeef S, Khouj E, Alahmadi F, et al
    An Ancient Founder GDF2 Variant Potentially Causes Semi-Dominant Non-Syndromic Pulmonary Arterial Hypertension.
    Clin Genet. 2026;110:289-298.
    PubMed         Abstract available
    
    

    
    Clin Respir J

14. XIAOTONG G, Yuchun F, Ting J, Xia C, et al
    Role of alpha-SMA, NOX4, Fibronectin, and HIF-1alpha in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension.
    Clin Respir J. 2026;20:e70218.
    PubMed         Abstract available
    
    
15. GREEN JL, Costin V, Armstrong I, Thompson AR, et al
    How Do Sleep Difficulties Interact With Anxiety, Depression and Health-Related Quality of Life in Pulmonary Hypertension?
    Clin Respir J. 2026;20:e70220.
    PubMed         Abstract available
    
    

    
    Cureus

16. DEB G, Emmanuel J, Bacon JL, Wong S, et al
    Multidisciplinary Management of the Rare Coexistence of Multiple Endocrine Neoplasia Type 1 and Chronic Thromboembolic Pulmonary Hypertension: A Case Report.
    Cureus. 2026;18:e114115.
    PubMed         Abstract available
    
    
17. PELLONI F, De Perna ML, Moschovitis G
    Pulmonary Hypertension in a 19-Year-Old Patient Due to a Mutation in the Bone Morphogenetic Protein Receptor Gene: A Case Report.
    Cureus. 2026;18:e111973.
    PubMed         Abstract available
    
    
18. SHAHANE S, Acharya S, Challawar R, Unas J, et al
    Fulminant Pulmonary Hypertension Due to Pulmonary Lymphangitic Carcinomatosis and Tumor Embolism From Occult Pulmonary Adenocarcinoma.
    Cureus. 2026;18:e111909.
    PubMed         Abstract available
    
    

    
    Curr Opin Pulm Med

19. ZEDER K, Kovacs G
    Current hot topics in pulmonary hypertension.
    Curr Opin Pulm Med. 2026;32:363-364.
    PubMed        
    
    
20. TADJKARIMI J, Lynn E, Desai S, Kouranos V, et al
    Recent updates in advanced pulmonary sarcoidosis.
    Curr Opin Pulm Med. 2026;32:491-499.
    PubMed         Abstract available
    
    
21. BUDHRAM B, Bonnet S, Weatherald J
    Promising signalling pathways for the treatment of pulmonary arterial hypertension.
    Curr Opin Pulm Med. 2026;32:410-423.
    PubMed         Abstract available
    
    

    
    Eur Heart J Digit Health

22. NASCIMENTO I, Fernandes CJCDS
    How should patient knowledge trigger clinical action in artificial intelligence-enabled pulmonary hypertension care?
    Eur Heart J Digit Health. 2026;7:ztag123.
    PubMed        
    
    

    
    Eur Radiol

23. GODINAS L, Gerges C, Revel MP, Prokop M, et al
    ESR Bridges: chronic thromboembolic pulmonary hypertension: new developments in imaging and treatment-a multidisciplinary view.
    Eur Radiol. 2026 Aug 5. doi: 10.1007/s00330-026-12781.
    PubMed        
    
    

    
    Eur Respir J

24. MORRIS TA, Dakaeva K, Alotaibi M, McGuire WC, et al
    Chronic thromboembolism phenotypes after acute pulmonary embolism: identification with the SEARCH algorithm.
    Eur Respir J. 2026;68:2501562.
    PubMed         Abstract available
    
    
25. FRANK BS, Beghetti M, Berger RMF, Bonnet D, et al
    Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension.
    Eur Respir J. 2026 Aug 6:2600327. doi: 10.1183/13993003.00327-2026.
    PubMed         Abstract available
    
    
26. WEATHERALD J, Hambly N
    Shining light on a dark prognosis: prognostic factors in pulmonary hypertension associated with interstitial lung disease.
    Eur Respir J. 2026;68:2600894.
    PubMed        
    
    

    
    Eur Respir Rev

27. PRINS SE, Blake MJ, Helke KL, Di Salvo T, et al
    Large animal models of right heart failure due to pulmonary hypertension: a bridge to translational success.
    Eur Respir Rev. 2026;35:260015.
    PubMed         Abstract available
    
    

    
    Expert Opin Drug Saf

28. WANG L, Mao Z, Zheng P, Zi G, et al
    Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database.
    Expert Opin Drug Saf. 2026;25:1553-1566.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

29. GENC HZ, Ceylan H, Kamali H, Recep E, et al
    Clinical effects of persistent pulmonary hypertension in newborns diagnosed with transposition of the great arteries.
    Front Cardiovasc Med. 2026;13:1888066.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

30. ZHU H, Li B, Wang X, Huang L, et al
    Mechanistic investigation of Midkine-Notch2 signaling in suppressing pulmonary artery smooth muscle cell apoptosis and promoting vascular remodeling in hypoxic pulmonary hypertension.
    Front Pharmacol. 2026;17:1788582.
    PubMed         Abstract available
    
    

    
    Heart Lung Circ

31. TAGER D, Raeisi-Giglou P, Naal T, Jawad A, et al
    Sitting Challenge During Right Heart Catheterisation in Adults with Postcapillary Pulmonary Hypertension.
    Heart Lung Circ. 2026 Aug 6:S1443-9506(26)00201.
    PubMed        
    
    

    
    Histochem Cell Biol

32. TEMPEL L, Schrepper A, Berndt A, Schulze PC, et al
    Longitudinal progression of tissue remodeling in experimental pulmonary hypertension is accompanied by a continuously increasing re-expression of extra domain A-containing fibronectin.
    Histochem Cell Biol. 2026;164:74.
    PubMed         Abstract available
    
    

    
    Hum Mutat

33. PANDE SA, Chan Joiner H, Szafranski P, Gambin T, et al
    Complex Genomic Rearrangement Involving the TBX4 Promoter Manifesting With Variable Expressivity in a Five-Generation Family.
    Hum Mutat. 2026;2026:7278477.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

34. YOSHIDA K, Toth E, Duijvelaar E, Neep B, et al
    Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2026;15:e047945.
    PubMed         Abstract available
    
    

    
    J Assoc Physicians India

35. PARIMI VP, Tejaswini RN
    A Complex Case of Systemic Sclerosis with Concurrent Breast Malignancy and Treatment-related Complications.
    J Assoc Physicians India. 2026;74.
    PubMed         Abstract available
    
    

    
    J Cell Mol Med

36. SHEN L, Ma H, Yu Y, Xu Y, et al
    Inhibiting HIF-1alpha-Induced miR-663b Improves Pulmonary Arterial Hypertension by Reducing Dysfunctions of PASMCs Through Repressing Sirt1-ZBP1-Mediated PANoptosis.
    J Cell Mol Med. 2026;30:e71285.
    PubMed         Abstract available
    
    

    
    J Hypertens

37. ZHANG MJ, Bo YC, Shi JZ, Xu MD, et al
    The association of cardiovascular health with new-onset pulmonary hypertension and the mediating role of proteomic signatures.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004409.
    PubMed         Abstract available
    
    
38. JI H, Ma S, Bao W, Li X, et al
    Transcriptomic analysis identifies novel ferroptosis-related biomarkers and therapeutic targets in pulmonary arterial hypertension.
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004374.
    PubMed         Abstract available
    
    

    
    J Perinatol

39. ELGENDY MM, Nath S
    Pulmonary hypertension and acute hypoxic respiratory failure in preterm neonates.
    J Perinatol. 2026 Aug 8. doi: 10.1038/s41372-026-02858.
    PubMed         Abstract available
    
    

    
    J Rheumatol

40. ABOABAT A, Al-Hammad A, Alhussin A, AlQutub S, et al
    Real-World Adherence to Systemic Sclerosis Quality Indicators: A Single-Center Quality of Care Study.
    J Rheumatol. 2026;53:894-898.
    PubMed         Abstract available
    
    

    
    J Vis Exp

41. WHITE YN, Douglass M, Cathcart R, Van Boerum J, et al
    Echocardiography Assessment of Cardiac Function and Pulmonary Hypertension in Lambs.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    JACC Heart Fail

42. FAUVEL C, Jaque PC, Liu Y, Lee SW, et al
    Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality.
    JACC Heart Fail. 2026;14:103151.
    PubMed         Abstract available
    
    

    
    Lancet

43. MCLAUGHLIN VV, Solum D, Lachant D, Ataya A, et al
    Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.
    Lancet. 2026 Jul 28:S0140-6736(26)01011-1. doi: 10.1016/S0140-6736(26)01011.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

44. QIN S, Shang L, Su D, Ye B, et al
    Development and validation of a nomogram prediction model for mild pulmonary arterial hypertension risk in children with left-to-right shunt congenital heart disease.
    Medicine (Baltimore). 2026;105:e50136.
    PubMed         Abstract available
    
    

    
    Niger Med J

45. MICHAEL A, Abdallah RJ, Ogiator AB, Ejideh AO, et al
    Use of Oral Sildenafil in the Management of Persistent Pulmonary Hypertension of the Newborn: A Case Report and Review of Literature.
    Niger Med J. 2026;67:364-370.
    PubMed         Abstract available
    
    

    
    Pediatr Cardiol

46. KWAN LT, Del Mundo RJS, McCown ME, Fremed MA, et al
    Estimating Exercise Intensity Using Heart Rate Methods in Children and Young Adults with Pulmonary Hypertension.
    Pediatr Cardiol. 2026 Aug 7. doi: 10.1007/s00246-026-04411.
    PubMed         Abstract available
    
    

    
    Pediatr Res

47. SADOWSKA-KRAWCZENKO I, Hozejowski R, Mazela J, Wroblewska-Seniuk K, et al
    Pulmonary comorbidities and response to surfactant in late preterm infants: a multicenter cohort study.
    Pediatr Res. 2025 Dec 1. doi: 10.1038/s41390-025-04634.
    PubMed         Abstract available
    
    

    
    Pharmacol Ther

48. SHI JZ, Ye JS, An XR, Cheng G, et al
    Metabolic reprogramming in pulmonary arterial hypertension.
    Pharmacol Ther. 2026;286:109085.
    PubMed         Abstract available
    
    

    
    Placenta

49. TSOI SM, Gasper C, Maltepe E, Chidboy MA, et al
    Placental abnormalities of malperfusion, inflammation, and meconium are associated with neonatal pulmonary vascular disease.
    Placenta. 2026;182:341-347.
    PubMed         Abstract available
    
    

    
    Psychol Res Behav Manag

50. XIONG J, Zhai Y, Yu A, Wang L, et al
    Mediating Effects of Fear of Movement and Self-Efficacy Between Illness Perception and Health-Related Quality of Life in Pulmonary Hypertension.
    Psychol Res Behav Manag. 2026;19:617450.
    PubMed         Abstract available
    
    

    
    Pulm Circ

51. ROUSSET MC, Sullivan RT, Brown AM, Eagle SR, et al
    The Heterogeneity of Long-Term Cardiopulmonary Outcomes in Children Born Preterm May Benefit from Pulmonary Hypertension-Specialty Outpatient Follow-Up.
    Pulm Circ. 2026;16:e70380.
    PubMed         Abstract available
    
    
52. BUBER I, Heerdt P, Singh I, Sevgican CI, et al
    Right Ventricular to Left Ventricular (RV/LV) Blood Pool T2 Ratio Is Associated With Invasive Hemodynamics Across Pulmonary Hypertension Subgroups.
    Pulm Circ. 2026;16:e70381.
    PubMed         Abstract available
    
    

    
    Res Sq

53. BHARTI D, Kolodiazhna T, Kacar S, Varghese MV, et al
    Poly-Pharmacologic Disruption of the Proliferative-to-Mesenchymal Fate Branch Point Reverses EndMT and Pulmonary Hypertension.
    Res Sq [Preprint]. 2026 Jul 23:rs.3.rs-9306408. doi: 10.21203/rs.3.rs-9306408.
    PubMed         Abstract available
    
    

    
    Rheumatology (Oxford)

54. REN H, Ding N, Yu X, Teng J, et al
    Lung disease in adult-onset Still's disease: a Chinese cohort study.
    Rheumatology (Oxford). 2026;65:keag375.
    PubMed         Abstract available
    
    

    
    Zh Nevrol Psikhiatr Im S S Korsakova

55. SAMUSHIYA MA, Klyushnik TP, Zateyshchikov DA, Tertyshnik AM, et al
    [The biological role of neuroinflammation in the pathogenesis of mental disorders associated with pulmonary hypertension].
    Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126:7-14.
    PubMed         Abstract available
    
    

    
    Zhonghua Jie He He Hu Xi Za Zhi

56. XIAO QX, Li JJ, Ding YJ, Li QY, et al
    [Early efficacy and safety of sotatercept in the treatment of pulmonary arterial hypertension in a Chinese population: a single-center case series analysis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:834-839.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum